RA, Forbion and Sanofi Ventures appear to back new eye drug from Korea

June 18, 2026 09:40 AM EDT FinancingStartups RA, For­bion and Sanofi Ven­tures ap­pear to back new eye drug from Ko­rea Kyle LaHucik Biotech Correspondent The trend con­tin­ues in which big-name ven­ture in­vestors band to­geth­er to back new com­pa­nies with an ex­per­i­men­tal med­i­cine de­vel­oped by an­oth­er biotech. RA Cap­i­tal and … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER